Abstract
Platelet-activating factor (PAF) is a low molecular weight phospholipid which enhances human monocyte cytotoxicity for tumor cells. In the current studies, the capacity of PAF to stimulate release of tumor necrosis factor α (TNFα) by human monocytes was assessed. PAF induced maximal TNFα synthesis 2–3 hr after monocyte stimulation as assessed by dot blotting of cell-associated TNFα using polyclonal anti-TNF antibody. Maximal net release of TNFα occurred 5–16 hr after monocyte stimulation, as assessed by a specific ELISA. Dose-response studies revealed that a maximal two- to three-fold increase in release of TNFα occurs at 10–100 pM PAF. LysoPAF and the optical isomer of PAF did not stimulate release of TNFα, suggesting that stimulation is mediated by specific PAF receptors. Scatchard analysis of [3H]PAF binding to monocyte membranes revealed 651±495 binding sites/monocyte with a Kd of 4.7±4.2×10−10M. PAF is a structurally unique activator of monocytes whose interactions with TNFα and other cytokines may be critical to host defense against tumors.
Similar content being viewed by others
Abbreviations
- BSA:
-
bovine serum albumin
- enantioPAF:
-
3-O-hexadecyl-2-acetyl-sn-glycero-1-phosphocholine
- IFNγ:
-
γ Interferon
- lysoPAF:
-
1-O-hexadecyl-sn-glycero-3-phosphocholine
- PGE2 :
-
prostaglandin E2
- MTT:
-
[3-(4,5-dimethylthiazol)2-yl)-2,5-diphenyltetrazolium bromide]
- PAF:
-
platelet-activating factor, 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine
- TNFα:
-
tumor necrosis factor α
References
Winslow, C.M., and Lee, M.L. (1987)New Horizons in Platelet-Activating Factor Research, John Wiley and Sons, New York.
Snyder, F. (1987)Platelet-Activating Factor and Related Lipid Mediators, Plenum Press, New York.
Valone, F.H., and Epstein, L.B. (1988)J. Immunol. 141, 3945–3950.
Elstad, M.R., Prescott, S.M., McIntyre, T.M., and Zimmerman, G.A. (1989)J. Immunol. 140, 1618–1624.
Sperling, R.I., Robin, J-L., Kylander, K.A., Lee, T.H., Lewis, R.A., and Austen, K.F. (1987)J. Immunol. 139, 4186–4191.
Malavasi, F., Tetta, C., Funaro, A., Bellone, G., Ferrero, E., Franzone, A.C., Dellabona, P., Rusci, R., Matera, L., Camussi, G., and Caligaris-Cappio, F. (1986)Proc. Natl. Acad. Sci. USA 83, 2443–2447.
Lynch, J.M., and Henson, P.M. (1986)J. Immunol. 137, 2653–2661.
Sisson, J.H., Prescott, S.M., McIntyre, T.M., and Zimmerman, G.A. (1987)J. Immunol. 138, 3918–3926.
McIntyre, T.M., Zimmerman, G.A., Satoh, K., and Prescott, S.M. (1985)J. Clin. Invest. 76, 271–280.
Yasaka, T., Boxer, L.B., and Baehner, R.L. (1982)J. Immunol. 128, 1939–1944.
Valone, F.H., and Goetzl, E.J. (1983)Immunology 48, 141–148.
Rola-Pleszczynski, M., Pouliot, C., Turcotte, S., Pignol, B., Braquet, P., and Bouvrette, L. (1988)J. Immunol. 140, 3547–3552.
Dulioust, A., Vivier, E., Salem, P., Benveniste, J., and Thomas, Y.I. (1988)J. Immunol. 140, 240–245.
Gebhardt, B.M., Braquet, P., Bazan, H., and Bazan, N. (1988)Immunopharmacology 15, 11–20.
Hayashi, H., Kudo, I., and Inoue, H. (1985)J. Biochem. (Tokyo) 97, 1737–1741.
Pignol, P., Sylvie, H., Mencia-Huerta, J-M., and Rola-Pleszczynski, M. (1987)Prostaglandins 33, 931–938.
Barthelson, R.A., Valone, F.H., Debs, R., and Philip, R. (1988)FASEB J. 2, A1228.
Valone, F.H., Philips, R., and Debs, R.J. (1988)Immunology 64, 715–718.
Espevik, T., and Nissen-Meyer J. (1986)J. Immunol. Methods 95, 99–105.
Mosmann, T.R., and Fong, T.A.T. (1989)J. Immunol. Methods 116, 151–158.
O'Flaherty, J.T., Surles, J.R., Redman, J., Jacobson, D., Piantadosi, C., and Wykle, R.L. (1986)J. Clin. Invest. 78, 381–388.
Valone, F.H. (1988)J. Immunol. 140, 2389–2394.
Spengler, R.N., Spengler, M.L., Strieter, R.M., Remick, D.G., Larrick, J.W., and Kunkel, S.L. (1988)Cellular Immunol. 114, 385–397.
Valone, F.H. (1987) inPlatelet-Activating Factor and Related Lipid Mediators (Snyder, F., ed.), Plenum Press, New York, pp. 137–152.
Grandel, K.E., Farr, R.S., Wanderer, A.A., Eisenstadt, T.C., and Wasserman, S.J. (1985)New Engl. J. Med. 313, 405–409.
Shalit, M., Valone, F.H., Atkins, P.C., Ratnoff, W.D., Goetzl, E.J., and Zweiman, B. (1989)J. Allerg. Clin. Immunol. 83, 691–696.
Bonavida, B., Mencia-Huerta, J-M., and Braquet, P. (1989)Int. Arch. Allergy Appl. Immunol. 88, 157–160.
Kornbluth, R., and Edgington, T.S. (1986)J. Immunol. 137, 2585–2591.
Dubois, C., Bissonnette, E., and Rola-Pleszczynski, M. (1989)J. Immunol. 153, 964–970.
Le, J., and Vilcek, J. (1987)Lab. Invest. 56, 234–248.
Xiao-ming, S., and Hsueh, W. (1988)J. Clin. Invest. 81, 1328–1331.
Author information
Authors and Affiliations
About this article
Cite this article
Ruis, N.M., Rose, J.K. & Valone, F.H. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids 26, 1060–1064 (1991). https://doi.org/10.1007/BF02536502
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536502